Biochemistry of bacterial type I DNA topoisomerases.

Y. Tse‐Dinh

DOI: https://doi.org/10.1016/S1054-3589(08)60538-4

Advances in Pharmacology

Abstract:

What problem does this paper attempt to address?

Antineoplastic effect of tetrandrine on primary cancer cells isolated from ascites

Jing YAN,Ting-ting WANG,Xiao-ping QIAN,Bao-rui LIU

DOI: https://doi.org/10.3969/j.issn.1673-5269.2008.24.008

2008-01-01

Abstract:Objective: To study the effect of tetrandrine on primary cancer cells isolated from the ascites of patients with metastatic cancers. Methods: Primary cancer cells were isolated from the ascites of patients (n = 21). Compared with culture cell lines BGC-823, LOVO and SMMC-7721, the response of these cancer cells to tetrandrine and chemotherapeutic agents commonly used in clinical were determined by WST-8 assay. Quantitative RT-PCR was used to examine the role of apoptotic associated genes Survivin and Bcl-2 in the antineoplastic effect of tetrandrine. Results: The primary cancer cells isolated from effusions showed a sensitivity to tetrandrine with IC 50 values of 32.96 μm, similar than that in the established cell lines(P>0.05). The antineoplastic effect of tetrandrine on primary cancer cells isolated from gastric, colon cancers and other cancers was found no statistic significance (P > 0.05). Cancer cells of 2 cases isolated from the effusions were resistant to tetrandrine, which also had the increased tolerance to docetaxel, cisplatin and 5-fluorouracil. A significant down-regulation role of tetrandrine on Survivin and Bcl-2 mRNA was obeserved in some primary cancer cells and cell lines (P < 0.05). Conclusion: Tetrandrine may have potential antineoplastic effect on primary cancer cells, especially those chemotherapetic-resistant cells.
Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines

Jia Wei,Baorui Liu,Lifeng Wang,Xiaoping Qian,Yitao Ding,Lixia Yu

DOI: https://doi.org/10.1007/s00280-007-0416-9

2007-01-01

Cancer Chemotherapy and Pharmacology

Abstract:Purpose Tetrandrine (Tet), a bis-benzylisoquinoline alkaloid that was isolated from the dried root of Hang-Fang-Chi ( Stephania tetrandra S. Moore ), is well known as processing a marked antitumor effect in vitro and in vivo. The aim of this study was to assess the interaction between tetrandrine and chemotherapeutic agents widely used in gastric cancer treatment, and to investigate the influence of tetrandrine on chemotherapeutic agent-associated gene expression and apoptosis. Methods Synergistic interaction on human gastric cancer BGC-823 and MKN-28 cells was evaluated using the combination index (CI) method. The double staining with both Annexin-V-FITC and PI was employed to distinguish the apoptotic cells from living cells. Expression of chemotherapeutic agent-associated genes, i.e., excision repair cross-complementing 1 (ERCC1), thymidylate synthase (TS), class III β-tubulin (β-tubulin III) and tau, of BGC-823 cells with or without tetrandrine treatment were measured by real-time quantitative PCR. Results Tetrandrine had a synergistic effect on the cytotoxicity of chemotherapeutic agents in both two gastric cancer cell lines. The combination of tetrandrine and chemotherapeutic agents could also induce apoptosis in a synergistic manner. Tetrandrine could suppress the mRNA expression of ERCC1, TS, β-tubulin III and tau. Most prominently, ERCC1, TS and β-tubulin III mRNA levels were markedly suppressed at 0.29-, 0.12- and 0.60-fold, respectively, by the presentation of tetrandrine. Conclusion Tetrandrine appears a promising candidate for combining with three chemotherapeutic agents. The possible mechanisms might be the synergistic apoptotic effect and the downregulation of chemotherapeutic agent-associated genes.
Novel sulfonyl-substituted tetrandrine derivatives for colon cancer treatment by inducing mitochondrial apoptosis and inhibiting PI3K/AKT/mTOR pathway

Jie Ling,Xiao Li,Maolin Wang,Chaozheng Zhang,Yilan Liu,Xin Zhang,Changqun Liu,Qing Ren,Yingjie Zeng,Chuanqi Wang,Ying Chen,Chen Sun,Hongyu Chen,Yi Zuo,Xiujun Cao,Yun Deng,Bo Ren,Defang Li,Jun Lu

DOI: https://doi.org/10.1016/j.bioorg.2023.107069

Abstract:Tetrandrine (TET) possesses multiple pharmacological activities and could suppress tumor proliferation via PI3K pathway inhibition. However, inferior antitumor activity and potential toxicity limit its clinical application. In the present study, a series of 14-sulfonamide and sulfonate TET derivatives were designed, synthesized, and evaluated for biological activities. Through structural-activity relationship studies, compound 3c with α, β-unsaturated carbonyl group exhibited the most potent activity against all tested tumor cell lines (including Hela, HCT116, HepG2, MCF-7, and SHSY5Y), as well as negligible toxicity against normal cell lines LO2 and HEK293. Additionally, compound 3c effectively inhibited HCT116 and CT26 cell proliferation in vitro with increased cell proportion in the G2/M phase, activated the mitochondrial apoptosis pathway, and induced colon cancer cell apoptosis by suppressing the PI3K/AKT/mTOR pathway. The further molecular docking results confirmed that compound 3c is potentially bound to multiple residues in PI3K with a stronger binding affinity than TET. Ultimately, compound 3c dramatically suppressed tumor growth in the CT26 xenograft tumor model, without noticeable visceral toxicity detected in the high-dose group. In summary, compound 3c might present new insights for designing new PI3K inhibitors and be a potential candidate for colon cancer treatment.
Mechanism of Tetrandrine in Combination with Droloxifen to Reverse Multidrug Resistance in Leukemia

Bao-An Chen,Ai-ling Su,Feng Gao,Jian Cheng,Jia-Hua Ding,Chong Gao,Yun-yu Sun,Jun Wang,Gang Zhao,Ning-Na Chen,Hui-Hui Zhao,Xiao-Ping Pei

DOI: https://doi.org/10.1182/blood.v110.11.4172.4172

IF: 20.3

2007-01-01

Blood

Abstract:Objective: The study aims to investigate the effect of Tetrandrine (Tetrandrine, Tet) in combination with Droloxifen (Droloxifen, DRL) on the expression of NF-κB(nuclear factor kappaB) of K562 and K562/A02 cell lines and the reversal mechanism of this combination. Method: The activation of NF-κB in K562 and K562/A02 cell lines and the effect of Tet,DRL alone or in combination on NF-κB were determined with Immunocytochemistry and Western blotting respectively. Results: K562/A02 cells displayed higher level of NF-κB protein expression than their parental K562 cells; The application of Tet or DRL alone or in combination had no effect on NF-κB expression in K562 cells at 6h and 12h; Tet and DRL used alone or in combination could significantly down-regulate NF-κB protein expression in nucleaus of K562/A02 cells. The effect was more significant in combination of Tet and DRL than the application of single drug. This decrease became more significant at 12h than at 6h. Conclusions: Activation of NF-κB may be involved in the mechanism of MDR of K562/A02 cell line; Inhibition of NF-κB activation may be involved in the mechanism of multidrug resistance reversal to K562/A02 line of Tet and DRL.
Anticancer effect of tetrandrine on primary cancer cells isolated from ascites and pleural fluids.

Baorui Liu,Tingting Wang,Xiaoping Qian,Guangxia Liu,Lixia Yu,Yitao Ding

DOI: https://doi.org/10.1016/j.canlet.2008.03.059

IF: 9.756

2008-01-01

Cancer Letters

Abstract:The present study was designed to examine the effect of tetrandrine on primary cancer cells isolated from the ascites or pleural fluids of patients with metastatic cancers.Primary cancer cells were isolated from the pleural fluids (n=13) or ascites (n=21) of patients. Compared with culture cell lines, the response of these cancer cells to tetrandrine and chemotherapeutic agents commonly used in clinical practice were determined by WST-8 assay. Tetrandrine-induced apoptosis in primary cancer cells was determined by Annexin V-FITC assay. Quantitative RT-PCR was used to examine the role of apoptotic associated genes in the anticancer effect of tetrandrine.The primary cancer cells isolated from effusions showed sensitivity to tetrandrine with IC50 values of 38.23+/-25.77microM, similar to the IC50 in established cell lines. Patients with gastric cancers were more sensitive to tetrandrine than patients with lung cancers (P=0.04). Four cancer cells isolated from effusions were resistant to tetrandrine, which also had increased tolerance to docetaxel, cisplatin and 5-fluorouracil. We also observed a weak but significant correlation between sensitivity to tetrandrine and cellular expression of bcl-2 (P=0.035, r=-0.364).Using cancer cells isolated from the ascites or pleural fluids, this study shows the potential anticancer effect of tetrandrine against primary cancer cells.
Design, Synthesis, and Biological Evaluation of N14-Amino Acid-Substituted Tetrandrine Derivatives as Potential Antitumor Agents against Human Colorectal Cancer

Yu-Chan Wang,Rong-Hong Zhang,Sheng-Cao Hu,Hong Zhang,Dan Yang,Wen-Li Zhang,Yong-Long Zhao,Dong-Bing Cui,Yong-Jun Li,Wei-Dong Pan,Shang-Gao Liao,Meng Zhou

DOI: https://doi.org/10.3390/molecules27134040

IF: 4.6

2022-06-24

Molecules

Abstract:As a typical dibenzylisoquinoline alkaloid, tetrandrine (TET) is clinically used for the treatment of silicosis, inflammatory pulmonary, and cardiovascular diseases in China. Recent investigations have demonstrated the outstanding anticancer activity of this structure, but its poor aqueous solubility severely restricts its further development. Herein, a series of its 14-N-amino acid-substituted derivatives with improved anticancer effects and aqueous solubility were designed and synthesized. Among them, compound 16 displayed the best antiproliferative activity against human colorectal cancer (HCT-15) cells, with an IC50 value of 0.57 μM. Compared with TET, 16 was markedly improved in terms of aqueous solubility (by 5-fold). Compound 16 significantly suppressed the colony formation, migration, and invasion of HCT-15 cells in a concentration-dependent manner, with it being more potent in this respect than TET. Additionally, compound 16 markedly impaired the morphology and motility of HCT-15 cells and induced the death of colorectal cancer cells in double-staining and flow cytometry assays. Western blot results revealed that 16 could induce the autophagy of HCT-15 cells by significantly decreasing the content of p62/SQSTM1 and enhancing the Beclin-1 level and the ratio of LC3-II to LC3-I. Further study showed that 16 effectively inhibited the proliferation, migration, and tube formation of umbilical vein endothelial cells, manifesting in a potent anti-angiogenesis effect. Overall, these results revealed the potential of 16 as a promising candidate for further preclinical studies.

chemistry, multidisciplinary,biochemistry & molecular biology
[Inhibitory Effect of Tetrandrine on Angiogenesis].

Xiao-Ping Qian,Bao-Rui Liu,Jing Hu,Min Li,Wen-Jing Hu,Jing Sun,Li-Xia Yu

DOI: https://doi.org/10.3321/j.issn:1000-467x.2008.10.007

2008-01-01

Abstract:BACKGROUND & OBJECTIVES:Angiogenesis plays an important role in tumorigenesis and metastasis. This study was to investigate the inhibitory effect and mechanism of tetrandrine on angiogenesis in vitro and in vivo.METHODS:MTT assay was used to observe the effect of tetrandrine on the proliferation of human umbilical vein endothelial cells (HUVECs) and human colorectal carcinoma LoVo cells. Transwell migration assay and tube formation assay were used to observe the impact of tetrandrine on cell migration and tube forming ability of HUVECs. LoVo cells were transplanted into nude mice. Microvessel density (MVD) was measured in nude mouse xenografts after intragastric administration of tetrandrine.RESULTS:Tetrandrine (2-8 microg/mL) inhibited the proliferation of HUVECs (24.6%-76.9%) and LoVo cells (11.6%-14.0%) after 48 h treatment. When HUVECs were incubated with 2-8 microg/mL tetrandrine, the number of tubules was reduced and the lumen lost its integrity after 24 h; the number of migrating HUVECs was decreased after 12 h as compared with the control group (P < 0.001). Furthermore, MVD was much less in LoVo cell xenografts treated with 80mg/kg tetrandrine than in those treated with normal saline (P = 0.035).CONCLUSIONS:Tetrandrine effectively suppresses angiogenesis in vitro, which may be through inhibiting cell proliferation, migration and tube-formation, inducing apoptosis and suppressing DNA synthesis of HUVECs. Tetrandrine also has an antiangiogenic effect on LoVo cell xenografts in nude mice.
Proteomic Analysis of Anti-Tumor Effects by Tetrandrine Treatment in Hepg2 Cells

Zhixiang Cheng,Keming Wang,Jia Wei,Xiang Lu,Baorui Liu

DOI: https://doi.org/10.1016/j.phymed.2010.03.018

IF: 6.656

2010-01-01

Phytomedicine

Abstract:Tetrandrine (TET), a bis-benzylisoquinoline alkaloid isolated from the root of Hang-Fang-Chi (Stephenia tetrandra S Moore), exhibits broad pharmacological effects, including anti-tumor activity. Recently, the beneficial effects of TET on cytotoxicity towards tumor cells, radiosensitization, circumventing multidrug resistance, normal tissue radioprotection, and antiangiogenesis have been examined extensively. To explore the potential molecular mechanism of the anti-tumor effect of TET, we applied proteomic tools to profile the proteins in HepG2 cells subjected to TET treatment. The levels of 39 proteins in cells exposed to TET (IC₅₀=5±0.6 μg/ml) for 48 h were observed to undergo significant alterations. Six proteins were identified by matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS) using peptide fingerprinting from 10 protein spots (density difference >1.5-fold between the control and TET-treated group). Among them, 5 proteins were downregulated (proteasome activator complex subunit 3, 40S ribosomal protein S12, phosphoglycerate mutase 1, destrin, transaldolase) and 1 protein was upregulated (guanylate kinase 1) by TET treatment in HepG2 cells as determined by spot volume (P<0.05). Most of the identified proteins were associated with tumor growth, migration, and anti-tumor drug resistance. These data will be helpful in elucidating the molecular mechanism of TET's anti-tumor effect in HepG2 cells.
Antagonistic effect of tetrandrine on multidrug resistance of breast cancer cells and the antioxidant mechanism

Yuan HUANG,Dong-Hai JIANG,Wei-Min FAN

DOI: https://doi.org/10.7620/zgfybj.j.issn.1001-4411.2017.11.70

2017-01-01

Abstract:Objective To research the antagonistic effect of tetrandrine on multidrug resistance of breast cancer cells and the probable antioxidant mechanism.Methods The parental BCap37 cell screening was used to establish Bads 200 breast cancer resistant cell model,then the cells were treated by tetrandrine combined with paclitaxel for 24,48,and 72 hours,respectively.Bads 200 breast cancer resistant cells cultured by normal method and simple paclitaxel were selected as control group and simple drug group,respectively.MTT assay was used to detect proliferation activity of cells in the three groups.Flow-cytometry was used to analyze the proportions of cells during different phases in the three groups.RT-PCR was used to detect the expression levels of endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS).Results The inhibiting effect of tetrandrine combined with paclitaxel on proliferation of Bads 200 breast cancer resistant cells was significant,showing a time-dependent manner.Compared with control group,the apoptotic rate of Bads 200 breast cancer resistant cells increased gradually after treated by tetrandrine combined with paclitaxel for 24,48,and 72 hours,respectively (P＜0.01).The proportions of Bads 200 breast cancer resistant cells at S stage and G2/M stage decreased gradually,and the proportion of Bads 200 breast cancer resistant cells at G0/G1 stage increased gradually (P＜ 0.01).Compared with control group,the expression level of iNOS in tetrandrine group decreased,while the expression levels of NO and eNOS increased.The results of RT-PCR were coincidence with the results of cell spectrophotometer method.Conclusion Tetrandrine can significantly inhibit proliferation of Bads 200 breast cancer resistant cells,the mechanism is correlated with antioxidant effect,up-regualtion of eNOS expression,and down-regulation of iNOS expression.
Dissection of the antitumor mechanism of tetrandrine based on metabolite profiling and network pharmacology

Cheng-Jun Liu,Hong-Xin Li,Yong-Ming Zhang,Wei Shi,Feng-Xiang Zhang

DOI: https://doi.org/10.1002/rcm.9662

2024-01-15

Abstract:Rationale: Tetrandrine, the Q-marker in Stephaniae Tetrandrae Radix, was proven to present an obvious antitumor effect. Until now, the metabolism and antitumor mechanism of tetrandrine have not been fully elucidated. Methods: The metabolites of tetrandrine in rats were profiled using ultra-high-performance liquid chromatography coupled with time-of-flight mass spectrometry. The potential antitumor mechanism of tetrandrine in vivo was predicted using network pharmacology. Results: A total of 30 metabolites were characterized in rats after ingestion of tetrandrine (10 mg/kg), including 0 in plasma, 7 in urine, 11 in feces, 9 in liver, 8 in spleen, 4 in lung, 5 in kidney, 5 in heart, and 4 in brain. This study was the first to show the metabolic processes demethylation, hydroxylation, and carbonylation in tetrandrine. The pharmacology network results showed that tetrandrine and its metabolites could regulate AKT1, TNF, MMP9, MMP2, PAK1, and so on by involving in proteoglycan tumor pathway, PI3K-Akt signaling pathway, tumor pathway, MAPK signaling pathway, and Rap1 signaling pathway. Conclusions: The metabolism features of tetrandrine and its potential antitumor mechanism were summarized, providing data for further pharmacological validation.
Tetrandrine Inhibits Epithelial-Mesenchymal Transition in IL-6-Induced HCT116 Human Colorectal Cancer Cells

Shih-Chang Tsai,Jai-Sing Yang,Wei-Che Wu

DOI: https://doi.org/10.2147/ott.s324552

IF: 4

2021-08-01

OncoTargets and Therapy

Abstract:INTRODUCTION: Patients with colorectal cancer (CRC) often develop distant metastases, which significantly reduces the 5-year survival rate. Epithelial-mesenchymal transition (EMT) is a crucial process for the invasion and metastasis of cancer cells. Tetrandrine has been reported to inhibit the viability and EMT of CRC cells; however, to the best of our knowledge, the molecular mechanism remains undetermined.METHODS: The MTT assay was used to determine HCT116 cell viability. Wound healing and Transwell assays were used to determine that cell migration and invasion, respectively. Western blotting analysis was performed to detect the expression of migration-related genes. Four different lengths of the E-cadherin gene promoter were constructed and cloned into pGL3 reporter plasmids to evaluate E-cadherin gene promoter activity.RESULTS: The results of the MTT assay revealed that tetrandrine inhibited HCT116 cell viability, with an IC50 value of 7.2 μM following 24 h of treatment. Tetrandrine inhibited IL-6-induced cell migration and invasion, respectively. Tetrandrine regulates the expression of migration-related genes in IL-6-stimulated HCT116 cells. Tetrandrine significantly downregulated the expression and enzyme activity of MMP-2 in IL-6-stimulated HCT116 cells. In addition, tetrandrine restored E-cadherin gene promoter activity.CONCLUSION: The findings of the present study suggested that tetrandrine may inhibit EMT in IL-6-stimulated HCT116 cells; therefore, it may represent a potential drug for CRC.

oncology,biotechnology & applied microbiology
Effect of Tetrandrine Combined with Daunorubicin on Expressions of P21 and P-gp in K562/A02 Cells

Bao-An Chen,Jing Li,Jian Chen,Feng Gao,Ya-Nan Wu,Min-Sheng Zhu,Jia-Hua Ding,Chong Gao,Xin-Chen Sun,Wen-Lin Xu,Xue-Mei Wang

2009-01-01

Abstract:This study was aimed to investigate the reversal effect of Tetrandrine (TET) combined with daunorubicin (DNR) on multidrug resistance (MDR) of K562/A02 cells and its relation to P21, P-gp and their genes so as to provide the new theoretic evidence for clinical use of TET. The experiments were divided into 4 groups: control group (DNR alone), combined 1 group (DNA+0.5 mg/L TET), combined 2 group (DNR+1.0 mg/L TET) and combined 3 group (DNR+2.0 mg/L TET). The expressions of P21, P-gp and mdr-1 gene in K562/A02 cells of different groups were detected by Western blot, flow cytometry and semi-quantitative PCR respectively. The results showed that the expression of P21 was enhanced along with increasing of TET concentration, the expression of P-gp was reduced along with increasing of TET concentration and expression of mdr-1 gene was almost not observed in K562 cells, but the high expression of mdr-1 gene was seen in K562/A02 cells, furthermore, the expression of mdr-1 gene in K562/A02 cells increasingly was reduced along with increasing of TET concentration. It is concluded that the TET possesses the reversal effect on multiple drug resistance of K562/A02 cells with concentration dependence, the reversal effect of TET may be related to up-regulation of P21 expression and down-regulation of P-gp and mdr-1 gene expressions in K562/A02 cells.
Pharmacodynamic Materials and Mechanisms of Compound Scutellariae Radix Granules for Colorectal Cancer: A Network Pharmacology, Molecular Docking and Cell Experiments Study

Yadong Xing,Min Wu,Shijie Zhong,Hui Zhang,Aiping Zheng

DOI: https://doi.org/10.1177/1934578x241257828

IF: 1.496

2024-07-01

Natural Product Communications

Abstract:Background: Compound Scutellariae Radix Granules (CSRG) are used to treat gastrointestinal diseases, including colorectal cancer (CRC), which is the second leading cause of cancer-related deaths. Studies have demonstrated that CSRG have anti-CRC effects; however, the exact molecular mechanisms remain unclear. Methods: This study used network pharmacology and molecular docking to identify the active ingredients in CSRG and assess CRC-related genes and pathways. After that, the effect of CSRG on HT29 cells was observed in vitro. Cell Counting Kit-8 detection, Western blot, and flow cytometry with AnnexinV-FITC/PI double staining experiments were used to observe the effects of CSRG on the proliferation, apoptosis and other effects of HT-29 cells. Moreover, the effects of CSRG and IGF-I (PI3K/AKT agonist) on HT-29 cell biological behaviors were gauged. Results: Naringenin, quercetin, licochalcone A, acacetin, wogonin, baicalein, kaempferol, and isorhamnetin were the key active ingredients in CSRG, which affect CRC through five genes: mitogen-activated protein kinase 3 and 1, tumor protein 53, signal transducer and activator of transcription 3, and RELA proto-oncogene, NF-kB subunit. The molecular docking experiments predicted the activity of the active ingredients in CSRG against their intended target, each of which could stably bind the corresponding CRC target. The enrichment analysis indicate that CSRG played a synergistic effect in regulating the process of apoptosis and cell proliferation, and that multiple pathways were participated in CSRG-related CRC treatment. Cell experiments results demonstrated that the PI3k–Akt pathway may be critical pathways. Besides, Tp53 was found tightly linked to apoptosis. Moreover, the suppressive effect of CSRG on HT29 cell malignant phenotypes was reversed by IGF-I. Conclusion: CSRG are an anti-colon cancer herb containing multiple components, involving multiple target genes and signaling pathways. CSRG inhibited colon cancer cell proliferation and induced apoptosis, which may be related to its inhibition of the PI3K/Akt pathway and activation of the Tp53 pathway.

chemistry, medicinal,food science & technology
Design, synthesis and in vitro anticancer research of novel tetrandrine and fangchinoline derivatives

Xiu-Zheng Gao,Xu-Tao Lv,Rui-Rui Zhang,Yang Luo,Mu-Xuan Wang,Jia-Shu Chen,Yu-Kai Zhang,Bin Sun,Jin-Yue Sun,Yu-Fa Liu,Chao Liu,Xiu-zheng Gao,Xu-tao Lv,Rui-rui Zhang,Mu-xuan Wang,Jia-shu Chen,Yu-kai Zhang,Jin-yue Sun,Yu-fa Liu

DOI: https://doi.org/10.1016/j.bioorg.2021.104694

IF: 5.307

2021-04-01

Bioorganic Chemistry

Abstract:Cancer treatment is one of the major public health issues in the world. Tetrandrine (Tet) and fangchinoline (d-Tet) are two bis-benzyl isoquinoline alkaloids extracted from Stephania tetrandra S. Moore, and their antitumor activities have been confirmed. However, the effective dose of Tet and d-Tet were much higher than that of the positive control and failed to meet clinical standards. Therefore, in this study, as a continuation of our previous work to study and develop high-efficiency and low-toxic anti-tumor lead compounds, twenty new Tet and d-Tet derivatives were designed, synthesized and evaluated as antitumor agents against six cancer cell lines (H460, H520, HeLa, HepG-2, MCF-7, SW480 cell lines) and BEAS-2B normal cells by CCK-8 analysis. Ten derivatives showed better cytotoxic effects than the parent fangchinoline, of which 4g showed the strongest cell growth inhibitory activity with an IC50 value of 0.59 μM against A549 cells. Subsequently, the antitumor mechanism of 4g was studied by flow cytometry, Hoechst 33258, JC-1 staining, cell scratch, transwell migration, and Western blotting assays. These results showed that compound 4g could inhibit A549 cell proliferation by arresting the G2/M cell cycle and inhibiting cell migration and invasion by reducing MMP-2 and MMP-9 expression. Meanwhile, 4g could induce apoptosis of A549 cells through the intrinsic pathway regulated by mitochondria. In addition, compound 4g inhibited the phosphorylation of PI3K, Akt and mTOR, suggesting a correlation between blocking the PI3K/Akt/mTOR pathway and the above antitumor activities. These results suggest that compound 4g may be a future drug for the development of new potential drug candidates against lung cancer.

biochemistry & molecular biology,chemistry, organic
Tetrandrine Enhances Radiosensitization in Human Hepatocellular Carcinoma Cell Lines

Xiao-mei Zhao,Wei-xu Hu,Zhi-Feng Wu,Yi-xing Chen,Zhao-chong Zeng

DOI: https://doi.org/10.1667/rr14981.1

2018-01-01

Radiation Research

Abstract:The goal of this study was to determine whether tetrandrine enhanced radiosensitization in different hepatocellular carcinoma cell lines and to elucidate the potential mechanism. We also tested whether PA28γ was regulated by tetrandrine. The human hepatocellular carcinoma cell lines HepG2 and LM3 were divided into six groups: control; low-dosage (0.5 or 5 μg/ml) tetrandrine alone; high-dosage (1.0 or 10 μg/ml) tetrandrine alone; irradiation alone; irradiation with low-dosage (0.5 μg/ml or 5 μg/ml) tetrandrine; and irradiation with high-dosage (1.0 μg/ml or 10 μg/ml) tetrandrine. Colony-forming assays were performed. Expression of cyclin and apoptosis-related proteins, including cyclin B1, phosphorylated cyclin-dependent kinase 1 [phospho-CDC2 (Tyr15)], Bax and caspase-3, as well as PA28γ expression, were evaluated using Western blot analysis. Apoptosis rate and cell cycle distribution were examined using flow cytometry analysis. Tetrandrine enhanced radiosensitivity in HepG2 and LM3 cells, as characterized by a narrower shoulder area and steeper linear area, and the enhanced radiosensitization increased with tetrandrine dosage. After tetrandrine treatment, the apoptosis rate significantly increased, whereas the proportion of cells in the G2 phase dramatically decreased in dose- and time-dependent manners after irradiation. However, the effect of reverse G2 arrest was weaker in p53-mutant cells (LM3 cells). Finally, we observed that tetrandrine downregulated PA28γ expression. Moreover, when PA28γ was downregulated, apoptosis and cell cycle distribution were also altered; however, the effects were weaker in p53-mutant cells. Therefore, we propose that tetrandrine-mediated apoptosis induction and G2 arrest attenuation are at least partly mediated by PA28γ.
Fatty metamorphosis of the liver in malignant neoplasia. Special reference to carcinoma of the breast

F. Lanza,R. Nelson

DOI: https://doi.org/10.1002/1097-0142(196804)21:4<699::AID-CNCR2820210422>3.0.CO;2-5

IF: 6.9209

1968-04-01

Cancer

Abstract:Fatty metamorphosis of the liver was found in an unusually large number of percutaneous needle liver biopsies in patients having mammary carcinoma with suspected metastases; this prompted a study of this abnormality in patients with cancer in general. The autopsy records of 1744 patients and percutaneous liver biopsy reports of 489 patients with malignant neoplasia were reviewed. Fatty metamorphosis was found in 66 (2.8%) of autopsies and 36 (7.3%) of liver biopsies. In cancer of the breast the incidence of fatty metamorphosis on biopsy (21.0%) exceeded that for all other cancers combined or for any other single tumor type, while at autopsy the frequency (5.9%) exceeded that of all other cancers (3.5%). In both autopsy and biopsy series there was a fatty metamorphosis ratio of 2:1 female to male patients.
Tetrandrine sensitizes nasopharyngeal carcinoma cells to irradiation by inducing autophagy and inhibiting MEK/ERK pathway

Jun Wang,Zhouzhou Yao,Xiaoping Lai,Hongwei Bao,Yue Li,Shuaixiang Li,Lihong Chang,Gehua Zhang

DOI: https://doi.org/10.1002/cam4.3356

IF: 4.711

2020-08-11

Cancer Medicine

Abstract:Radioresistance was the main reason for local recurrence and metastasis of nasopharyngeal carcinoma. Tetrandrine is reported as an antitumor drug via inducing cell cycle arrest and apoptosis. In this study, the radiosensitization effects of maximum noncytotoxic doses of tetrandrine in nasopharyngeal carcinoma were analyzed both in vitro and in vivo , using MTT assay, western blot, TUNEL, and HE staining. It was found that the maximum dose of tetrandrine inhibited the phosphorylation of ERK and MEK induced by irradiation, and significantly enhanced irradiation‐induced cell growth inhibition in nasopharyngeal carcinoma cells CNE1, CNE2, and C666‐1. The ERK activator and overexpression of ERK reversed the radiosensitization effect of tetrandrine. About 50 mg/kg of tetrandrine which was used as the maximum noncytotoxic dose of tetrandrine in vivo , enhanced the radiosensitivity of the xenograft tumor and increased the apoptosis rate of the xenograft tumor cells caused by irradiation, while did not raise the side effect of the treatment. Moreover, tetrandrine increased autophagy in nasopharyngeal carcinoma cells. These results suggested that the maximum noncytotoxic dose of tetrandrine sensitized nasopharyngeal carcinoma to irradiation by inhibiting MEK/ERK pathway and inducing autophagy.

oncology
Cranium bifidum with meningoencephalocoele.

S. Bandi,M. Chandel

Indian Pediatrics

Abstract:
Tilianin Extracted From Dracocephalum moldavica L. Induces Intrinsic Apoptosis and Drives Inflammatory Microenvironment Response on Pharyngeal Squamous Carcinoma Cells via Regulating TLR4 Signaling Pathways

Hailun Jiang,Li Zeng,Xueqi Dong,Shuilong Guo,Jianguo Xing,Zhuorong Li,Rui Liu

DOI: https://doi.org/10.3389/fphar.2020.00205

IF: 5.6

2020-03-04

Frontiers in Pharmacology

Abstract:Human pharyngeal squamous cell carcinoma is highly invasive and proliferative, and exhibits an extremely low 5-year survival rate due to poor understanding of the underlying pathogenic mechanisms, and lack of efficient treatment. It has been shown that the immunosuppressive microenvironment created by tumor cells impairs the immune response against tumor progression, thereby affecting the prognosis for tumor patients. Thus, to improve therapeutic efficacy, it is critical to identify novel drugs with immunoinflammatory modulatory properties to treat tumor immune evasion. Tilianin, the main ingredient of total flavonoids extracted from Dracocephalum moldavica L., has multiple biological functions, including cardiovascular protective effects, anti-tumor effects, and anti-inflammatory effects. In the present study, the suppressive effects of tilianin on human pharyngeal squamous cell carcinoma were investigated and the underlying mechanisms in regulating the tumor immunosuppressive microenvironment were explored. The cytotoxicity of tilianin on FaDu cells was determined by CCK-8 and clone formation assays. Moreover, the levels of toll-like receptor 4 (TLR4) signaling transduction and apoptotic pathways were determined by immunocytochemical, biochemical, and molecular biological technologies. In addition, the maturation of dendritic cells (DCs) that were co-cultured in supernatant of FaDu cells was evaluated by flow cytometry to investigate alterations in immune system function. For mechanistic exploration, TLR4 siRNA, p38 siRNA, c-Jun N-terminal kinase (JNK) siRNA, and p65 siRNA were used as loss-of-function target evaluation of tilianin therapy. Combined, these results showed that tilianin treatment increased cytotoxicity as well as the apoptotic population of FaDu cells in a dose-dependent manner. Furthermore, tilianin treatment decreased the level of anti-apoptotic markers Bcl-2 and Bcl-xL, increased the level of apoptotic factors Bad and Bax, and stimulated cytochrome c release, caspase-3 and poly ADP ribose polymerase (PARP) activation in FaDu cells. Furthermore, our findings indicated that tilianin treatment activated TLR4/p38/JNK/NF-κB signaling pathways and increased the release of inflammatory cytokines. This promoted the maturation of DCs to enhance immune system function in the tumor microenvironment. Moreover, the effects of tilianin on immune system function were abolished by TLR4 siRNA and p65 siRNA. In conclusion, these findings suggested that tilianin may be of immunotherapeutic value for inhibiting human pharyngeal squamous cell carcinoma.

pharmacology & pharmacy
Inhibition of laryngeal cancer stem cells by tetrandrine

Xiangyan Cui,Dong Xiao,Xin Wang

DOI: https://doi.org/10.1097/CAD.0000000000000803

Abstract:Cancer stem cells play a fundamental role in the growth, metastasis, recurrence, and chemoresistance of cancers of various origins; therefore, targeting these cells may prospectively help to eradicate cancer cells from patients. In this study, the effect of tetrandrine on the proliferation of CD133-positive (CD133) Hep-2 cells was examined to characterize its potential for targeting cancer stem cells in laryngeal cancer.The stem cell population of Hep-2 cells was isolated by magnetic-activated cell sorting against CD133, treated with different concentrations of tetrandrine, and assessed for cell cycle progression, proliferation, and migration. The mechanism of tetrandrine inhibition was also investigated.Our in vitro assay indicated that 20 μg/ml tetrandrine significantly inhibited the viability of CD133 Hep-2 cells (P < 0.01). Further cell cycle profiling showed a nearly 50% reduction of the S-phase cells after tetrandrine treatment, suggesting that tetrandrine inhibited DNA synthesis as well as cell proliferation. At the molecular level, tetrandrine induced downregulation of Bcl-2 and simultaneous upregulation of Bax and caspase-3 as well as enhanced cell apoptosis.Our results demonstrated that tetrandrine inhibited the cell viability and proliferation of CD133 Hep-2 cells by reducing the number of cells in the S-phase of the cell cycle and enhancing cell apoptosis.

Biochemistry of bacterial type I DNA topoisomerases.

Antineoplastic effect of tetrandrine on primary cancer cells isolated from ascites

Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines

Novel sulfonyl-substituted tetrandrine derivatives for colon cancer treatment by inducing mitochondrial apoptosis and inhibiting PI3K/AKT/mTOR pathway

Mechanism of Tetrandrine in Combination with Droloxifen to Reverse Multidrug Resistance in Leukemia

Anticancer effect of tetrandrine on primary cancer cells isolated from ascites and pleural fluids.

Design, Synthesis, and Biological Evaluation of N14-Amino Acid-Substituted Tetrandrine Derivatives as Potential Antitumor Agents against Human Colorectal Cancer

[Inhibitory Effect of Tetrandrine on Angiogenesis].

Proteomic Analysis of Anti-Tumor Effects by Tetrandrine Treatment in Hepg2 Cells

Antagonistic effect of tetrandrine on multidrug resistance of breast cancer cells and the antioxidant mechanism

Dissection of the antitumor mechanism of tetrandrine based on metabolite profiling and network pharmacology

Tetrandrine Inhibits Epithelial-Mesenchymal Transition in IL-6-Induced HCT116 Human Colorectal Cancer Cells

Effect of Tetrandrine Combined with Daunorubicin on Expressions of P21 and P-gp in K562/A02 Cells

Pharmacodynamic Materials and Mechanisms of Compound Scutellariae Radix Granules for Colorectal Cancer: A Network Pharmacology, Molecular Docking and Cell Experiments Study

Design, synthesis and in vitro anticancer research of novel tetrandrine and fangchinoline derivatives

Tetrandrine Enhances Radiosensitization in Human Hepatocellular Carcinoma Cell Lines

Fatty metamorphosis of the liver in malignant neoplasia. Special reference to carcinoma of the breast

Tetrandrine sensitizes nasopharyngeal carcinoma cells to irradiation by inducing autophagy and inhibiting MEK/ERK pathway

Cranium bifidum with meningoencephalocoele.

Tilianin Extracted From Dracocephalum moldavica L. Induces Intrinsic Apoptosis and Drives Inflammatory Microenvironment Response on Pharyngeal Squamous Carcinoma Cells via Regulating TLR4 Signaling Pathways

Inhibition of laryngeal cancer stem cells by tetrandrine